BAYLOR COLLEGE OF MEDICINE - NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - TASK AREAS 2, 3, AND 4
Key Details
Description
NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - TASK AREAS 2, 3, AND 4
Context & Analysis
On Sep 27, 2023, Department of Health and Human Services obligated $14,521,767.54 to BAYLOR COLLEGE OF MEDICINE for nhlbi trans-omics for precision medicine (topmed) for the centralized omics resource (core) - task areas 2, 3, and 4. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: full and open competition. Performance is located in HOUSTON, TX. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.
Market context
- Recompete outlook
- Ended Sep 27, 2026 (30 days ago). Recompete signal as of Oct 25, 2026: 49/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
- Competition
- Competed. 58% of 201 awards in this market (Department of Health and Human Services awards in NAICS 541380 over the last 3 years) were competed; median 1 offers.
- Award size
- At $14.5M, this award is larger than 19 in 20 of the 201 priced Department of Health and Human Services awards in NAICS 541380 over the last 3 years (median $69K).
- Incumbent at this agency
- BAYLOR COLLEGE OF MEDICINE has 4 other awards from Department of Health and Human Services, totalling $4.7M, 2025–2026.
- Largest vendors in this market
By obligations, Department of Health and Human Services awards in NAICS 541380 over the last 3 years.
- EMORY UNIVERSITY — 10 awards, $85.0M
- GINKGO BIOWORKS, INC. — 1 award, $78.0M
- VERILY HEALTH INC. — 1 award, $42.3M
- THE BROAD INSTITUTE, INC — 4 awards, $35.5M
- NEW YORK GENOME CENTER, INC. — 6 awards, $16.8M
Computed from USAspending award data on Oct 25, 2026.
Contractor Information
Similar Awards
TRAVELER-BASED GENOMIC SURVEILLANCE PROGRAM
GINKGO BIOWORKS, INC.
$78.0M
WASTEWATER SURVEILLANCE TESTING
VERILY HEALTH INC.
$42.3M
INNOVATION FUNNEL FOR COVID-19 - VALIDATION CENTER
EMORY UNIVERSITY
$41.2M
STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
$38.8M
CENTRALIZED OMICS RESOURCE (CORE) YEAR 5
THE BROAD INSTITUTE, INC
$36.4M
Stay Updated
Get notified about new opportunities matching your interests.